Hollo V - Search Results

1

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.

van der Werf MJ, Ködmön C, Hollo V, Sandgren A, Zucs P. van der Werf MJ, et al. Among authors: hollo v. Euro Surveill. 2014 Mar 13;19(10):20733. doi: 10.2807/1560-7917.es2014.19.10.20733. Euro Surveill. 2014. PMID: 24650865 Free article.

2

Is tuberculosis crossing borders at the Eastern boundary of the European Union?

van der Werf MJ, Hollo V, Noori T. van der Werf MJ, et al. Among authors: hollo v. Eur J Public Health. 2013 Dec;23(6):1058-63. doi: 10.1093/eurpub/ckt098. Epub 2013 Jun 27. Eur J Public Health. 2013. PMID: 23813718 Free PMC article.

3

Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. Karo B, et al. Among authors: hollo v. Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087. Euro Surveill. 2015. PMID: 26676247 Free article.

4

The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.

Hollo V, Kotila SM, Ködmön C, Zucs P, van der Werf MJ. Hollo V, et al. Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171. Euro Surveill. 2016. PMID: 27035746 Free article.

5

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.

van der Werf MJ, Ködmön C, Zucs P, Hollo V, Amato-Gauci AJ, Pharris A. van der Werf MJ, et al. Among authors: hollo v. AIDS. 2016 Nov 28;30(18):2845-2853. doi: 10.1097/QAD.0000000000001252. AIDS. 2016. PMID: 27755106 Free PMC article.

6

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.

van der Werf MJ, Hollo V, Ködmön C, Dara M, Catchpole M. van der Werf MJ, et al. Among authors: hollo v. Eur Respir J. 2017 Mar 22;49(3):1601992. doi: 10.1183/13993003.01992-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28331041 Free PMC article.

7

Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.

de Vries G, Tsolova S, Anderson LF, Gebhard AC, Heldal E, Hollo V, Cejudo LS, Schmid D, Schreuder B, Varleva T, van der Werf MJ. de Vries G, et al. Among authors: hollo v. BMC Public Health. 2017 Apr 19;17(1):334. doi: 10.1186/s12889-017-4216-9. BMC Public Health. 2017. PMID: 28424062 Free PMC article.

8

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.

Karo B, Kohlenberg A, Hollo V, Duarte R, Fiebig L, Jackson S, Kearns C, Ködmön C, Korzeniewska-Kosela M, Papaventsis D, Solovic I, van Soolingen D, van der Werf MJ. Karo B, et al. Among authors: hollo v. Euro Surveill. 2019 Mar;24(12):1800392. doi: 10.2807/1560-7917.ES.2019.24.12.1800392. Euro Surveill. 2019. PMID: 30914081 Free PMC article.

9

Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us?

Hollo V, Amato-Gauci A, Kodmon C, Manissero D. Hollo V, et al. Euro Surveill. 2009 Mar 19;14(11):19151. Euro Surveill. 2009. PMID: 19317981 Free article.

10

Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control.

Manissero D, Hollo V, Huitric E, Kodmon C, Amato-Gauci A. Manissero D, et al. Among authors: hollo v. Euro Surveill. 2010 Mar 18;15(11):19514. Euro Surveill. 2010. PMID: 20338143 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters